NOVAVAX INC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $2.93B | $2.58B | $1.52B |
| FY2022 | $2.89B | $2.26B | $1.34B |
| FY2023 | $2.51B | $1.80B | $568.5M |
| FY2024 | $2.18B | $1.56B | $530.2M |
| FY2025 | $1.30B | $1.18B | $240.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $2.93B | $2.58B | $1.52B |
| FY2022 | $2.89B | $2.26B | $1.34B |
| FY2023 | $2.51B | $1.80B | $568.5M |
| FY2024 | $2.18B | $1.56B | $530.2M |
| FY2025 | $1.30B | $1.18B | $240.6M |